Cole CS, Dafoe A, Tietbohl CK, Jordan SR, Huebschmann AG, Lum HD, et al
In a public advisory on Wednesday, Health Canada said that as interest grows in GLP-1 products for weight loss, "some people may turn to unauthorized or counterfeit products, which could pose serious health risks because they have not been assessed by Health Canada for safety, effectiveness, or quality." The versions of the medications authorized for use in Canada are semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections)
Before starting any new prescription or over-the-counter medications, it is essential to consult your doctor
pentaphyllum gypenosides were investigated in Wistar rats
rare but serious concerns include neoplasia risk, carpal tunnel-like symptoms, or glucose intolerance
Read source Hansen KB, et al